Kura Oncology (KURA) Amortizatization of Intangibles (2015 - 2026)

Kura Oncology's (KURA) quarterly Amortizatization of Intangibles came in at $900000.0 in Q1 2026, down 66.19% year-on-year from $2.7 million in Q1 2025, and down 34.88% on a QoQ basis from $1.4 million in Q4 2025.

Kura Oncology (KURA) Amortizatization of Intangibles (2015 - 2026) Analysis & Trends

Kura Oncology (KURA) has 12 years of Amortizatization of Intangibles data on file, last reported at $900000.0 in Q1 2026.

  • On a quarterly basis, Amortizatization of Intangibles fell 66.19% year-over-year to $900000.0 in Q1 2026; TTM through Mar 2026 was $6.7 million, a 46.33% decrease from a year earlier, with the FY2025 full-year figure at $8.5 million, down 35.41% from the prior year.
  • Amortizatization of Intangibles for Q1 2026 stood at $900000.0, down from $1.4 million in the prior quarter.
  • Over the last five years, Amortizatization of Intangibles for KURA reached as high as $3.5 million in Q2 2024 and fell as low as -$1.1 million in Q1 2022.
  • Historically, Amortizatization of Intangibles has averaged $1.8 million across 5 years, with a median of $2.1 million in 2023.
  • Across the five-year window, Amortizatization of Intangibles surged 881.08% in 2023 and plunged 66.19% in 2026, its largest moves.
  • Year by year, Amortizatization of Intangibles stood at $654000.0 in 2022, then soared by 317.89% to $2.7 million in 2023, then gained by 5.56% to $2.9 million in 2024, then plunged by 52.1% to $1.4 million in 2025, then sank by 34.88% to $900000.0 in 2026.
  • Per Business Quant data, the three most recent Amortizatization of Intangibles figures were $900000.0 in Q1 2026, $1.4 million in Q4 2025, and $1.9 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn -
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn -
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn -
9 Revolution Medicines 37.35 Bn 37.35 Bn - 3.22 Mn
10 Kura Oncology 916.67 Mn 916.67 Mn 18.00 Mn 900,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 900,000.00
Mar 31, 2026 900,000.00
Dec 31, 2025 1.38 Mn
Dec 31, 2025 1.38 Mn
Sep 30, 2025 1.92 Mn
Sep 30, 2025 1.92 Mn
Jun 30, 2025 2.52 Mn
Jun 30, 2025 2.52 Mn
Mar 31, 2025 2.66 Mn
Mar 31, 2025 2.66 Mn
Dec 31, 2024 2.89 Mn
Dec 31, 2024 2.89 Mn
Sep 30, 2024 3.44 Mn
Sep 30, 2024 3.44 Mn
Jun 30, 2024 3.55 Mn
Jun 30, 2024 3.55 Mn
Mar 31, 2024 3.27 Mn
Mar 31, 2024 3.27 Mn
Dec 31, 2023 2.73 Mn
Dec 31, 2023 2.73 Mn